Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma
Pascale Mariani(Université Paris Sciences et Lettres), Shufang Renault(Université Paris Sciences et Lettres), François‐Clément Bidard(Inserm), Aurore Rampanou(Université Paris Sciences et Lettres), Nathalie Cassoux(Institut Curie), Vincent Servois(Université Paris Sciences et Lettres), Marion Chevrier(Zimmer Biomet (France)), Marc‐Henri Stern(Université Paris Sciences et Lettres), Anne Vincent‐Salomon(Université Paris Sciences et Lettres), Alexandre Houy(Inserm), Sophie Gardrat(Institut Curie), Manuel Rodrigues(Inserm), Benjamin Renouf(Institut Curie), Olivier Lantz(Inserm), Sergio Roman‐Roman(Université Paris Sciences et Lettres), Toulsie Ramtohul(Université Paris Sciences et Lettres), Gaëlle Pierron(Institut Curie), Sophie Piperno‐Neumann(Institut Curie)
Cited by 16
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2017|1.9k
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
|Cancer Cell|2018|1.7k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k